Panbela Therapeutics Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de Panbela Therapeutics?
El Est. EPS Q / Q de Panbela Therapeutics Inc. es 37.50%
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con est. eps q / q similar a Panbela Therapeutics
- AMN Healthcare Services tiene Est. EPS Q / Q de 36.99%
- Canoo tiene Est. EPS Q / Q de 37.14%
- CVB tiene Est. EPS Q / Q de 37.14%
- Redington (India) tiene Est. EPS Q / Q de 37.17%
- Marvell Technology Inc tiene Est. EPS Q / Q de 37.21%
- Mercedes-Benz AG tiene Est. EPS Q / Q de 37.33%
- Panbela Therapeutics tiene Est. EPS Q / Q de 37.50%
- Ashtead Plc tiene Est. EPS Q / Q de 37.68%
- Xilinx tiene Est. EPS Q / Q de 37.68%
- Colgate-Palmolive (India) tiene Est. EPS Q / Q de 37.79%
- Münchener Rückversicherungs-Gesellschaft AG tiene Est. EPS Q / Q de 37.80%
- Costamare Inc tiene Est. EPS Q / Q de 37.88%
- Colliers International tiene Est. EPS Q / Q de 37.89%